← FDA Drug Approvals (Drugs@FDA)

CEFTRIAXONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: DEVA HOLDING AS · Approved 2024-01-12

Drug application

FDA Application #

ANDA210197

Application type

Abbreviated New Drug Application (Generic)

Brand name

CEFTRIAXONE

Generic name

Ceftriaxone Sodium

Active ingredients

CEFTRIAXONE SODIUM

Dosage form

INJECTABLE

Route

INTRAMUSCULAR, INTRAVENOUS

Marketing status

Discontinued

Sponsor

DEVA HOLDING AS

First approval

2024-01-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown